AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine.

Amyloid A (AA) amyloidosis is a well-known consequence of chronic inflammatory diseases in which elevated plasma concentrations of serum amyloid A result in amyloid aggregation and organ damage. In this issue, Sikora et al. report, for the first time, an inherited form of AA amyloidosis occurring in the absence of systemic inflammation. This finding may provide novel insights into the pathogenesis of AA amyloidosis, allowing researchers to further dissect the role of inflammation from that of serum amyloid A. Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Citation

Laura Obici, Vittorio Bellotti. AA amyloidosis without systemic inflammation: when clinical evidence validates predictions of experimental medicine. Kidney international. 2022 Feb;101(2):219-221

Mesh Tags

Substances

PMID: 35065689

search → result